Tue 14'th Aug 2018
Ekso Bionics Holdings Stock Analysis
Technical stock analysis for Tue 14'th Aug 2018
|Shorts||5.44% ( 2018-07-31 )|
Ekso Bionics Holdings gained 8.21% in the last trading day, rising from $2.68 to $2.90 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 7 of the last 10 days and is up by 64.77% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 2.07 million more shares were traded than the day before. In total, 2.66 million shares bought and sold for approximately $7.70 million.
Ekso Bionics Holdings has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $2.36, a level that may pose a second chance to hit a runner. According to fan-theory $2.84 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.
Only positive signals in the chart today. Ekso Bionics Holdings holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $2.50 and $1.97. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday July 31, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
The stock holds a RSI14 at 78 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $2.75 and $2.40.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ekso Bionics Holdings finds support just below today's level at $2.75. If this is broken, then the next support from accumulated volume will be at $2.40 and $2.33.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.35 between high and low, or 13.26%. For the last week, the stock has had a daily average volatility of 14.82%.
The stock is extremely overbought on RSI14 (78). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stoploss: $2.75 (-5.33%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from pivot bottom found 10 days ago.)
Very Low Low Medium High Very High
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term period. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.Click for Top 5 Strong Buy Candidates
|EKSO $2.90 $0.22(8.21%)|
EKSO is up $0.22 today, but where's it headed in September?
|Zacks Investment Research is releasing its prediction for EKSO based on the 1-3 month system that more than doubles the S&P 500.
Click here – the EKSO analysis is free »